41 related articles for article (PubMed ID: 19410469)
21. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
22. [Boron delivery system for neutron capture therapy of cancer].
Nakamura H
Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
[No Abstract] [Full Text] [Related]
23. Progress in the field of compounds for boron neutron capture therapy.
Gabel D
Bull Cancer Radiother; 1996; 83 Suppl():186s-90s. PubMed ID: 8949777
[TBL] [Abstract][Full Text] [Related]
24. Boron complexes of porphyrins and related polypyrrole ligands: unexpected chemistry for both boron and the porphyrin.
Brothers PJ
Chem Commun (Camb); 2008 May; (18):2090-102. PubMed ID: 18438481
[TBL] [Abstract][Full Text] [Related]
25. Tumor targeting agents for neutron capture therapy.
Soloway AH; Alam F; Barth RF; Anisuzzaman AK; Bapat BV
Basic Life Sci; 1990; 54():37-47. PubMed ID: 2268247
[No Abstract] [Full Text] [Related]
26. Carboranyl thymidine analogues for neutron capture therapy.
Tjarks W; Tiwari R; Byun Y; Narayanasamy S; Barth RF
Chem Commun (Camb); 2007 Dec; (47):4978-91. PubMed ID: 18049729
[TBL] [Abstract][Full Text] [Related]
27. Boron-containing chlorins and tetraazaporphyrins: synthesis and cell uptake of boronated pyropheophorbide a derivatives.
Ratajski M; Osterloh J; Gabel D
Anticancer Agents Med Chem; 2006 Mar; 6(2):159-66. PubMed ID: 16529538
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro effects of boron and boronated compounds.
Benderdour M; Bui-Van T; Dicko A; Belleville F
J Trace Elem Med Biol; 1998 Mar; 12(1):2-7. PubMed ID: 9638606
[TBL] [Abstract][Full Text] [Related]
29. Talaporfin: LS 11, LS11, ME 2906, mono-L-aspartyl chlorin e6, NP e6, NPE 6, taporfin sodium.
Drugs R D; 2003; 4(1):69-71. PubMed ID: 12568643
[No Abstract] [Full Text] [Related]
30. Bacteriochlorophyll a, and its derivatives: chemistry and perspectives for cancer therapy.
Grin MC; Capital Em Cyrillicironov CA; Shtil AC
Anticancer Agents Med Chem; 2008 Aug; 8(6):683-97. PubMed ID: 18690829
[TBL] [Abstract][Full Text] [Related]
31. Boron containing oligonucleotides.
Schinazi RF; Lesnikowski ZJ
Nucleosides Nucleotides; 1998; 17(1-3):635-47. PubMed ID: 9708367
[No Abstract] [Full Text] [Related]
32. Current data regarding the structure-toxicity relationship of boron-containing compounds.
Farfán-García ED; Castillo-Mendieta NT; Ciprés-Flores FJ; Padilla-Martínez II; Trujillo-Ferrara JG; Soriano-Ursúa MA
Toxicol Lett; 2016 Sep; 258():115-125. PubMed ID: 27329537
[TBL] [Abstract][Full Text] [Related]
33. [Neutron capture therapy for glioblastoma].
Yamamoto T; Nakai K; Matsumura A
No Shinkei Geka; 2008 Apr; 36(4):293-302. PubMed ID: 18411794
[No Abstract] [Full Text] [Related]
34. The versatile chemistry of the [B20H18]2- ions: novel reactions and structural motifs.
Hawthorne MF; Shelly K; Li F
Chem Commun (Camb); 2002 Mar; (6):547-54. PubMed ID: 12120120
[TBL] [Abstract][Full Text] [Related]
35. Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy.
Soriano-Ursúa MA; Das BC; Trujillo-Ferrara JG
Expert Opin Ther Pat; 2014 May; 24(5):485-500. PubMed ID: 24456081
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo fluorescence monitoring of photosensitizers.
Pottier R
J Photochem Photobiol B; 1990 Jun; 6(1-2):103-9. PubMed ID: 2121927
[TBL] [Abstract][Full Text] [Related]
37. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
38. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.
Calabrese G; Nesnas JJ; Barbu E; Fatouros D; Tsibouklis J
Drug Discov Today; 2012 Feb; 17(3-4):153-9. PubMed ID: 21978988
[TBL] [Abstract][Full Text] [Related]
39. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
40. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
